Bayer to buy Perfuse

2026-07-01

Bayer shifts US glyphosate business to Ruveon after seeking tariffs on Chinese imports

Bayer is consolidating its U.S. glyphosate operations into its Ruveon unit after requesting tariffs on Chinese imports to address sustainability concerns. This restructuring aims to create a more nimb

reuters · 2026-07-01 17:08 UTC

2026-06-30

Bayer Seeks US Duties on Chinese-Made Glyphosate, Angering Farmers

Bayer petitioned U.S. authorities to impose duties on cheaper Chinese glyphosate imports, claiming predatory pricing threatens its domestic business. The move follows a Supreme Court victory on liabil

reuters · 2026-06-30 17:24 UTC

2026-05-05

Bayer to buy Perfuse Therapeutics in up to $2.45 billion deal

Bayer announced plans to acquire biopharmaceutical firm Perfuse Therapeutics for up to $2.45 billion to bolster its ophthalmology pipeline. The deal includes a $300 million upfront payment plus additi

reuters · 2026-05-05 23:45 UTC

Media coverage (3)

Bayer shifts US glyphosate business to Ruveon after seeking tariffs on Chinese importsreuters
Bayer Seeks US Duties on Chinese-Made Glyphosate, Angering Farmersreuters
Bayer to buy Perfuse Therapeutics in up to $2.45 billion dealreuters

Bayer to buy Perfuse

Bayer shifts US glyphosate business to Ruveon after seeking tariffs on Chinese imports

Bayer Seeks US Duties on Chinese-Made Glyphosate, Angering Farmers

Bayer to buy Perfuse Therapeutics in up to $2.45 billion deal

Media coverage (3)

Related topics